MARISHA DAWSON: Open Payments
NPI 1881372159 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 35 payments from 7 companies in 2025. Trend: 2023 $418 · 2024 $523 · 2025 $578
Food & beverage: $461Education: $117
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $171 |
| Vanda Pharmaceuticals Inc. | 12 | $162 |
| Janssen Pharmaceuticals, Inc | 11 | $139 |
| ABBVIE INC. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: FANAPT, INVEGA SUSTENNA, UZEDY, EPKINLY, COBENFY, REXULTI, INGREZZA.
Industry payments across OK — which companies pay providers there.
